Method and kit for diagnosing depression after acute coronary syndrome using homocysteine
Abstract:
This invention relates to a method of diagnosing the depression, and more particularly to a method and kit for diagnosing depression after acute coronary syndrome, by measuring the concentration of a specific biomarker in the blood of a patient suffering from acute coronary syndrome to predict depression after acute coronary syndrome.
Information query
Patent Agency Ranking
0/0